Search NASA⌕ Search

SEARCH · Search NASA

Results for “evaluation study”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 73 records · Page 4

Phase I/II Study Evaluating Early Tolerance in Breast Cancer Patients Undergoing Accelerated Partial Breast Irradiation Treated With the MammoSite Balloon Breast Brachytherapy Catheter Using a 2-Day Dose Schedule

Purpose: Initial Phase I/II results using balloon brachytherapy to deliver accelerated partial breast irradiation (APBI) in 2 days in patients with early-stage breast cancer are presented. Materials and Methods: Between March 2004 and August 2007, 45 patients received adjuvant radiation therapy after lumpectomy with balloon brachytherapy in a Phase I/II trial delivering 2800 cGy in four fractions of 700 cGy. Toxicities were evaluated using the National Cancer Institute Common Toxicity Criteria for Adverse Events v3.0 scale and cosmesis was documented at >=6 months. Results: The median age was 66 years (range, 48-83) and median skin spacing was 12 mm (range, 8-24). The median follow-up was 11.4 months (5.4-48 months) with 21 patients (47%) followed >=1 year, 11 (24%) >=2 years, and 7 (16%) >=3 years. At <6 months (n = 45), Grade II toxicity rates were 9% radiation dermatitis, 13% breast pain, 2% edema, and 2% hyperpigmentation. Grade III breast pain was reported in 13% (n = 6). At >=6 months (n = 43), Grade II toxicity rates were: 2% radiation dermatitis, 2% induration, and 2% hypopigmentation. Grade III breast pain was reported in 2%. Infection was 13% (n = 6) at <6 months and 5% (n = 2) at >=6 months. Persistent seroma >=6 months was 30% (n = 13). Fat necrosis developed in 4 cases (2 symptomatic). Rib fractures were seen in 4% (n = 2). Cosmesis was good/excellent in 96% of cases. Conclusions: Treatment with balloon brachytherapy using a 2-day dose schedule resulted acceptable rates of Grade II/III chronic toxicity rates and similar cosmetic results observed with a standard 5-day accelerated partial breast irradiation schedule.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Prospective study evaluating the use of IV contrast on IMRT treatment planning for lung cancer

Purpose: To investigate the impact of exclusively using intravenous (IV) contrast x-ray computed tomography (CT) scans on lung cancer intensity-modulated radiation therapy (IMRT) treatment planning. Methods: Eight patients with lung cancer (one small cell, seven nonsmall cell) scheduled to receive IMRT consented to acquisition of simulation CT scans with and without IV contrast. Clinical treatment plans optimized on the noncontrast scans were recomputed on contrast scans and dose coverage was compared, along with the γ passing rates. Results: IV contrast enhanced scans provided better target and critical structure conspicuity than the noncontrast scans. Using noncontrast scan as a reference, the median absolute/relative differences in mean, maximum, and minimum doses to the planning target volume (PTV) were −4.5 cGy/−0.09%, 41.1 cGy/0.62%, and −19.7 cGy/−0.50%, respectively. Regarding organs-at-risk (OARs), the median absolute/relative differences of maximum dose to heart was −13.3 cGy/−0.32%, to esophagus was −63.4 cGy/−0.89%, and to spinal cord was −16.3 cGy/−0.46%. The median heart region of interest CT Hounsfield Unit (HU) number difference between noncontrast and contrast scans was 136.4 HU (range, 94.2–161.8 HU). Subjectively, the regions with absolute dose differences greater than 3% of the prescription dose were small and typically located at the patient periphery and/or at the beam edges. The median γ passing rate was 0.9981 (range, 0.9654–0.9999) using 3% absolute dose difference/3 mm distance-to-agreement criteria. Overall, all evaluated cases were found to be clinically equivalent. Conclusions: PTV and OARs dose differences between noncontrast and contrast scans appear to be minimal for lung cancer patients undergoing IMRT. Using IV contrast scans as the primary simulation dataset could increase treatment planning efficiency and accuracy by avoiding unnecessary scans, manually region overriding, and planning errors caused by nonperfect image registrations.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

High Performance Computing Productivity Study - Evaluation of Parallel Tools Platform (PTP) Eclipse Plug-In

This report is a DARPA funded Work For Others (WFO) evaluation of the Parallel Tools Platform (PTP) version 5.0.3 (Released October 18, 2011). PTP is currently being developed and supported as an open source product managed by Project Lead Greg Watson and team at IBM plus several other contributors. The tool has been in development since 2005 with a goal of providing an infrastructure for the integration of high performance computing tools. Basic functionality such as source code editing, compiling, launching, and debugging, plus more advanced features including performance monitoring and deployment have been bundled into an Eclipse Integrated Development Environment (IDE) plug-in to give parallel application programmers the features and improved productivity gained from using a common, well established development platform. The evaluation encompasses the basic aspects of using PTP, beginning with the installation and configuration of the plug-in, followed by code development and debugging. Each aspect is evaluated based on the expectations of my experience as an Eclipse user and is presented in the following format: • Feature description • User Experience • Evaluation The feature description is based on the provided documentation for PTP and the ‘generic’ expectations of what the feature should provide. The user experience reveals the actual use and exercise of the feature – specifically in the context and perspective of the evaluation platform provided by Lawrence Livermore National Laboratory. The evaluation of each feature includes the overall outcome of the user experience, along with the expectations that were not met, met, or exceeded along with any issues that were encountered.

97 MATHEMATICS AND COMPUTING↗

Report for 2.2.1 Task 4: Software-Based Tools to Support Human-System Evaluation Studies

INL contracted IFE to develop custom software functionality to support INL’s control room simulator data collections. The tool described in this report provides functionality for authoring, managing and executing so-called micro task data collections (Hildebrandt and Eitrheim, 2015), where operators receive a long list of operational tasks, and the speed and accuracy of their response is measured. The tool consists of an editor, player and observer module. This report contains methodological background and a user guide.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗